MCLAUGHLIN JOHN PETER Insider Trading
Get the latest insider transactions of MCLAUGHLIN JOHN PETER. MCLAUGHLIN JOHN PETER is CEO in PDL BIOPHARMA, INC. ($PDLI) and Director in PDL BIOPHARMA, INC. ($PDLI) and President, CEO in PDL BIOPHARMA, INC. ($PDLI) and Director in ROCKWELL MEDICAL, INC. ($RMTI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Chief Executive Officer in ANESIVA, INC. ($CGTK) and President & CEO in ANESIVA, INC. ($CGTK) and Director in LENSAR, Inc. ($LNSR) and Director in Adverum Biotechnologies, Inc. ($AAVL). Discover the current value of MCLAUGHLIN JOHN PETER shares.
Address: C/O CORGENTECH INC. 650 GATEWAY BOULEVARD SOUTH SAN FRANCISCO 94080CA
MCLAUGHLIN JOHN PETER is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
CGTK | ANESIVA, INC. | Chief Executive Officer, President & CEO | 25,000 | 0.00 |
ADVM | Adverum Biotechnologies, Inc. | Director | 10,333 | 0.00 |
SGEN | Seagen Inc. | Director | 39,400 | 2,395,126.00 |
PDLI | PDL BIOPHARMA, INC. | Director, President, CEO | 477,934 | 1,056,234.14 |
RMTI | ROCKWELL MEDICAL, INC. | Director | 86,974 | 530,541.40 |
LNSR | LENSAR, Inc. | Director | 0 |
Insider Trading Transactions of MCLAUGHLIN JOHN PETER
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Mar 16 2021 | LNSR | LENSAR, Inc. | MCLAUGHLIN JOHN PETER | Director | Option Exercise | 8.62 | 13,445 | 115,896 | 13,445 |
Feb 02 2021 | LNSR | LENSAR, Inc. | MCLAUGHLIN JOHN PETER | Director | Option Exercise | 7.08 | 28,249 | 200,003 | 28,249 |
Dec 22 2020 | PDLI | PDL BIOPHARMA, INC. | MCLAUGHLIN JOHN PETER | Director | Sell | 2.62 | 50,000 | 131,200 | 477,934 |
Dec 22 2020 | PDLI | PDL BIOPHARMA, INC. | MCLAUGHLIN JOHN PETER | Director | Sell | 2.61 | 277,934 | 724,574 | 200,000 |
Aug 24 2020 | PDLI | PDL BIOPHARMA, INC. | MCLAUGHLIN JOHN PETER | Director | Buy | 0.00 | 25,826 | 0 | 527,934 |
Aug 24 2020 | PDLI | PDL BIOPHARMA, INC. | MCLAUGHLIN JOHN PETER | Director | Option Exercise | 3.63 | 118,671 | 430,776 | 118,671 |
May 20 2020 | RMTI | ROCKWELL MEDICAL, INC. | MCLAUGHLIN JOHN PETER | Director | Buy | 0.00 | 51,800 | 0 | 86,974 |
May 20 2020 | RMTI | ROCKWELL MEDICAL, INC. | MCLAUGHLIN JOHN PETER | Director | Option Exercise | 2.04 | 34,024 | 69,409 | 34,024 |
Sep 06 2019 | RMTI | ROCKWELL MEDICAL, INC. | MCLAUGHLIN JOHN PETER | Director | Buy | 0.00 | 22,559 | 0 | 22,559 |
Sep 06 2019 | RMTI | ROCKWELL MEDICAL, INC. | MCLAUGHLIN JOHN PETER | Director | Option Exercise | 2.56 | 28,372 | 72,632 | 28,372 |
Jul 08 2019 | PDLI | PDL BIOPHARMA, INC. | MCLAUGHLIN JOHN PETER | Director | Option Exercise | 3.00 | 126,050 | 378,150 | 126,050 |
Jan 09 2019 | PDLI | PDL BIOPHARMA, INC. | MCLAUGHLIN JOHN PETER | CEO | Sell | 0.00 | 123,449 | 0 | 502,108 |
Dec 28 2018 | PDLI | PDL BIOPHARMA, INC. | MCLAUGHLIN JOHN PETER | CEO | Sell | 0.00 | 627,228 | 0 | 625,557 |
Jun 12 2018 | PDLI | PDL BIOPHARMA, INC. | MCLAUGHLIN JOHN PETER | CEO | Option Exercise | 2.94 | 1,922,100 | 5,650,974 | 1,922,100 |
Dec 19 2017 | PDLI | PDL BIOPHARMA, INC. | MCLAUGHLIN JOHN PETER | CEO | Sell | 0.00 | 151,678 | 0 | 1,252,785 |
Mar 07 2017 | PDLI | PDL BIOPHARMA, INC. | MCLAUGHLIN JOHN PETER | President, CEO | Buy | 2.04 | 588,235 | 1,199,999 | 1,404,463 |
Dec 15 2016 | PDLI | PDL BIOPHARMA, INC. | MCLAUGHLIN JOHN PETER | President, CEO | Sell | 0.00 | 5,168 | 0 | 816,228 |
May 24 2016 | SGEN | SEATTLE GENETICS INC /WA | MCLAUGHLIN JOHN PETER | Director | Buy | 0.00 | 3,700 | 0 | 39,400 |
May 24 2016 | SGEN | SEATTLE GENETICS INC /WA | MCLAUGHLIN JOHN PETER | Director | Option Exercise | 38.82 | 9,260 | 359,473 | 9,260 |
Feb 17 2016 | AAVL | Adverum Biotechnologies, ... | MCLAUGHLIN JOHN PETER | Director | Buy | 0.00 | 8,333 | 0 | 10,333 |
Feb 17 2016 | AAVL | Adverum Biotechnologies, ... | MCLAUGHLIN JOHN PETER | Director | Option Exercise | 4.80 | 11,905 | 57,144 | 11,905 |
Jan 28 2016 | PDLI | PDL BIOPHARMA, INC. | MCLAUGHLIN JOHN PETER | President, CEO | Buy | 3.22 | 403,727 | 1,300,001 | 821,396 |
May 19 2015 | SGEN | SEATTLE GENETICS INC /WA | MCLAUGHLIN JOHN PETER | Director | Buy | 0.00 | 3,700 | 0 | 35,700 |
May 19 2015 | SGEN | SEATTLE GENETICS INC /WA | MCLAUGHLIN JOHN PETER | Director | Option Exercise | 39.94 | 9,260 | 369,844 | 9,260 |
Apr 23 2015 | AAVL | Adverum Biotechnologies, ... | MCLAUGHLIN JOHN PETER | Director | Buy | 0.00 | 2,000 | 0 | 2,000 |
Apr 23 2015 | AAVL | Adverum Biotechnologies, ... | MCLAUGHLIN JOHN PETER | Director | Option Exercise | 39.35 | 7,000 | 275,450 | 7,000 |
May 12 2006 | CGTK | ANESIVA, INC. | MCLAUGHLIN JOHN PETER | Chief Executive Offic ... | Option Exercise | 7.46 | 250,000 | 1,865,000 | 250,000 |
Nov 14 2005 | CGTK | ANESIVA, INC. | MCLAUGHLIN JOHN PETER | Chief Executive Offic ... | Option Exercise | 8.28 | 100,000 | 828,000 | 0 |
Nov 14 2005 | CGTK | ANESIVA, INC. | MCLAUGHLIN JOHN PETER | Chief Executive Offic ... | Option Exercise | 2.45 | 100,000 | 245,000 | 100,000 |
May 02 2005 | CGTK | ANESIVA, INC. | MCLAUGHLIN JOHN PETER | President & CEO | Option Exercise | 2.25 | 100,000 | 225,000 | 100,000 |
Mar 28 2005 | CGTK | ANESIVA, INC. | MCLAUGHLIN JOHN PETER | President & CEO | Sell | 0.00 | 25,000 | 0 | 274,603 |
Mar 28 2005 | CGTK | ANESIVA, INC. | MCLAUGHLIN JOHN PETER | President & CEO | Sell | 0.00 | 25,000 | 0 | 249,603 |
Mar 28 2005 | CGTK | ANESIVA, INC. | MCLAUGHLIN JOHN PETER | President & CEO | Buy | 0.00 | 25,000 | 0 | 25,000 |
Mar 28 2005 | CGTK | ANESIVA, INC. | MCLAUGHLIN JOHN PETER | President & CEO | Buy | 0.00 | 25,000 | 0 | 25,000 |
Jan 05 2005 | CGTK | ANESIVA, INC. | MCLAUGHLIN JOHN PETER | President & CEO | Option Exercise | 8.28 | 100,000 | 828,000 | 100,000 |
Nov 22 2004 | CGTK | ANESIVA, INC. | MCLAUGHLIN JOHN PETER | President & CEO | Buy | 0.00 | 2,000 | 0 | 299,603 |
Nov 16 2004 | CGTK | ANESIVA, INC. | MCLAUGHLIN JOHN PETER | President & CEO | Buy | 0.00 | 103 | 0 | 297,603 |
Aug 11 2004 | CGTK | ANESIVA, INC. | MCLAUGHLIN JOHN PETER | President & CEO | Buy | 1.20 | 10,000 | 12,000 | 297,500 |
Aug 11 2004 | CGTK | ANESIVA, INC. | MCLAUGHLIN JOHN PETER | President & CEO | Option Exercise | 1.20 | 10,000 | 12,000 | 265,000 |